Location History:
- St. Hubert, CA (1986 - 2004)
- St-Hubert, CA (1987 - 2006)
Company Filing History:
Years Active: 1986-2006
Title: The Innovative Contributions of Jean-Paul Daris
Introduction
Jean-Paul Daris, an accomplished inventor from St-Hubert, Canada, has made significant contributions to the field of pharmaceuticals with a total of 8 patents to his name. His work focuses on developing compounds that have profound implications in treating various diseases, particularly those related to growth factor receptors.
Latest Patents
Among his latest innovations are two notable patents. The first involves pyrrolotriazine compounds, which are designed to inhibit tyrosine kinase activity of growth factor receptors such as HER1, HER2, and HER4. These compounds are heralded for their potential as antiproliferative agents, offering new avenues for treating diseases linked to aberrant signal transduction pathways. The second patent pertains to cinnamide derivatives, which act as modulators of KCNQ potassium channels, showcasing Daris's diverse approach to addressing complex medical challenges.
Career Highlights
Jean-Paul Daris has had an illustrious career working with prestigious organizations such as Bristol-Myers Company and Bristol-Myers Squibb Company. His experience at these companies has allowed him to contribute significantly to the pharmaceutical field, advancing both research and practical applications of his inventions.
Collaborations
Throughout his career, Daris has collaborated with notable colleagues, including Alain Martel and Jacques Corbeil. These partnerships have facilitated the exchange of ideas and innovation, further enhancing the impact of his work in pharmaceuticals.
Conclusion
Jean-Paul Daris's dedication to innovation is evident through his impressive portfolio of patents and collaborations. His work continues to inspire advancements in the medical field, providing solutions to complex health issues and reaffirming his status as a noteworthy inventor in the realm of pharmaceuticals.